The Best of Canadian Science and Technology
Raytheon Technologies (Raytheon Technologies Stock Quote, Chart, News NYSE:RTX) has taken it on the chin since the start of the COVID-19 pandemic but … [Read more...] about Raytheon Technologies will survive, this fund manager says
AltaCorp Capital analyst David Kideckel says he’s encouraged by recent developments from Canadian LP Aurora Cannabis (Aurora Cannabis Stock Quote, … [Read more...] about Aurora Cannabis’s cost-cutting is encouraging, says AltaCorp
The advent of biosynthetic cannabis will be a boost for Canadian licensed producer Cronos Group (Cronos Group Stock Quote, Chart, News TSX:CRON), says … [Read more...] about Raymond James turns bullish on Cronos Group
If you’re looking for names ready to flourish in a post-COVID world, you should be thinking about Canadian IT consulting giant CGI Group (CGI Group … [Read more...] about You should be buying CGI Group at these prices, says Christine Poole
Airlines hit hard by the COVID-19 pandemic are itching to get passengers back on board, but social distancing rules are running up against the … [Read more...] about Discount carrier Flair Airlines struggles with social distancing
With new supply agreements in hand and a growing consumer demand for high-quality organic product, Vancouver-based Rubicon Organics (Rubicon Organics … [Read more...] about Rubicon Organics is a buy, says Mackie Research
Stifel GMP analyst Justin Keywood says investors can expect to see Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) use its … [Read more...] about Ahead of Q1 results, Stifel says buy Knight Therapeutics
National Bank Financial analyst Richard Tse is staying bullish on cloud-based supply chain management company Kinaxis (Kinaxis Stock Quote, Chart, … [Read more...] about Where is Kinaxis heading? Higher, says National Bank
Mackie Research analyst André Uddin says investors can expect long-term organic growth and margin improvements from specialty pharma company Medexus … [Read more...] about Medexus Pharma is “significantly undervalued”: Mackie Research
Disappointing quarterly results are cause for a downgrade for MediPharm Labs (MediPharm Labs Stock Quote, Chart, News TSX:LABS), says Mackie Research … [Read more...] about MediPharm Labs downgraded at Mackie Research
